China's revised National Ambient Air Quality Standards, which lower the annual fine particulate matter (PM2.5) limit to 25 micrograms per cubic meter (µg m⁻³), could substantially reduce premature deaths and accelerate progress toward the World Health Organization's 2040 goal of halving air-pollution-related mortality, according to a health impact assessment published in Environmental Science and Ecotechnology.
The study, led by researchers at Peking University Health Science Center and the Chinese Academy of Environmental Planning, estimates that full compliance with the 25 µg m⁻³ standard in 2024 would have averted approximately 233,668 premature deaths (95% uncertainty interval: 198,354–270,734), a 16.1% reduction from observed levels. In contrast, the former 35 µg m⁻³ standard would have averted only 53,985 deaths. The stricter limit would expand the share of the population above the regulatory threshold from 33% to 65%, meaning more than twice as many people would live in areas exceeding the standard and thus benefit from further air quality improvements.
The health gains are strongly disease-specific. Under the 25 µg m⁻³ scenario, mortality fell by 22.8% for chronic obstructive pulmonary disease (COPD), 18.4% for stroke, 18.4% for lung cancer, 18.0% for lower respiratory infections, and 16.0% for ischemic heart disease. Reductions were much smaller for dementia (1.4%) and type 2 diabetes (1.1%), with the dementia estimate requiring caution due to weaker evidence. Nationally, the PM2.5-attributable fraction of mortality declined from 32.5% in 2015 to 22.6% in 2024, reflecting the impact of clean air actions that cut population-weighted exposure from 62.8 to 29.7 µg m⁻³ over the same period.
Critically, the study quantifies how far the stricter standard advances the WHO 2040 halving target. Full compliance with the 35, 30, and 25 µg m⁻³ limits would increase PM2.5-specific progress toward that goal to 66.2%, 72.6%, and 83.4%, respectively. COPD alone would exceed the 50% halving benchmark under the 25 µg m⁻³ scenario, while dementia and type 2 diabetes would remain far behind. A sensitivity analysis using the Global Exposure Mortality Model confirmed the pattern, showing 3.9 times more deaths averted under 25 than 35 µg m⁻³.
These findings have direct implications for policy. The authors argue for health-oriented implementation of the revised standards, prioritizing regions with large populations and high PM2.5 exposure where compliance with 25 µg m⁻³ would yield the largest gains. They also recommend pairing air-quality control with older-adult protection, clinical prevention, and chronic-disease management. Because abatement costs are rising and population aging can offset exposure-related gains, future standards should be evaluated by disease-specific health returns, not compliance rates alone. The framework, detailed in the study available at 10.1016/j.ese.2026.100781, could inform other developing countries seeking to tighten PM2.5 limits while tracking progress toward the WHO 2040 target.
